Skip to main content
. 2012 Nov;56(11):5907–5915. doi: 10.1128/AAC.00770-12

Table 1.

B. subtilis strains, plasmids, and oligonucleotides used in this study

Strain, plasmid, or oligonucleotide Descriptiona Reference or source
Strains
    PDC134 W168 trpC2 Ω spoVD::Cm Pxyl-murE Ω amyE::xylR 19
    PDC204 W168 trpC2 Ω spoVD::Erm Pxyl-murE Ω 19
    RM29 W168 trpC2 Ω spoVD::Cm Pxyl-murE Ω amyE::xylR sacB::Spec R. Mercier
    TMB1075 PDC204 Ω spoVD::Erm Pxyl-murE Ω amyE::pTM1 This study
    TMB1077 PDC204 Ω spoVD::Erm Pxyl-murE Ω amyE::pER603 This study
    TMB1080 PDC204 Ω spoVD::Erm Pxyl-murE Ω amyE::pTM1, sacB::Spec This study
    TMB1082 PDC204 Ω spoVD::Erm Pxyl-murE Ω amyE::pER603, sacB::Spec This study
Plasmids
    pAC6 Bla amyElacZ Cat ′amyE (integrative promoter probe vector) 69
    pTM1 pAC6 PliaI-lacZ 30
    pER603 pAC6 PbceA-lacZ 55
Oligonucleotides
    liaI-fwd(RT) GGTATCGGAGCCATTATGCTC This study
    liaI-rev(RT) CCCATTCGTCATCAAAGTGAG This study
    bceA-fwd(RT) CGTCAGTATTATGGGTGCTTC This study
    bceA-rev(RT) GAATGGTTCCGTGACTGACCTG This study
a

Resistance cassettes: Bla, ampicillin; Cat, chloramphenicol; Spec, spectinomycin; Erm, erythromycin.